A. Anastasiadis

发表

In vitro Effects of the Farnesyltransferase Inhibitor Tipifarnib on Myelodysplastic Syndrome Progenitors

D. Margaritis, I. Kotsianidis, G. Bourikas, 2008, Acta Haematologica.

Hydroxyurea and Anagrelide Combination Therapy in Patients with Chronic Myeloproliferative Diseases Resistant or Intolerant to Monotherapy

D. Margaritis, I. Kotsianidis, G. Bourikas, 2009, Acta Haematologica.

The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways in Chronic Lymphocytic Leukemia

K. Stamatopoulos, I. Kotsianidis, M. Tsagiopoulou, 2021, Cancers.

Long‐term remission of lymphocytic hypereosinophilic syndrome with imatinib mesylate

D. Margaritis, I. Kotsianidis, C. Tsatalas, 2012, American journal of hematology.

CD1d expression as a prognostic marker for chronic lymphocytic leukemia

D. Margaritis, I. Kotsianidis, E. Spanoudakis, 2014, Leukemia & lymphoma.

Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia

D. Margaritis, E. Mantadakis, G. Martinis, 2016, Mediterranean journal of hematology and infectious diseases.

Proteolytic Matrix Metallopeptidases and Inhibitors in BCR-ABL1-Negative Myeloproliferative Neoplasms: Correlation with JAK2V617F Mutation Status

D. Margaritis, D. Margaritis, I. Kotsianidis, 2011, Acta Haematologica.

Successful treatment of lymph node extramedullary plasmacytoma with bortezomib

D. Margaritis, G. Bourikas, P. Prassopoulos, 2006, Annals of Hematology.

Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report

D. Margaritis, I. Kotsianidis, E. Spanoudakis, 2009, Cases journal.

Long-term bone marrow cultures (LTBMC) from essential thrombocythemia (ET) patients with or without JAK2617V>F mutation.

D. Margaritis, I. Kotsianidis, G. Bourikas, 2008, Leukemia research.